Cancer testis antigens in sarcoma: Expression, function and immunotherapeutic application

被引:35
作者
Wei, Ran [1 ,2 ]
Dean, Dylan C. [1 ]
Thanindratarn, Pichaya [1 ]
Hornicek, Francis J. [1 ]
Guo, Wei [2 ]
Duan, Zhenfeng [1 ]
机构
[1] Univ Calif Los Angeles, Dept Orthoped Surg, Sarcoma Biol Lab, David Geffen Sch Med, 615 Charles E Young Dr South, Los Angeles, CA 90095 USA
[2] Peking Univ Peoples Hosp, Musculoskeletal Tumor Ctr, 11 Xizhimen South St, Beijing 100044, Peoples R China
基金
美国国家卫生研究院;
关键词
Cancer testis antigen; Sarcoma; Expression; Function; Immunotherapy; T-CELL RESPONSES; TUMOR-ASSOCIATED ANTIGEN; CANCER/TESTIS ANTIGENS; PROGNOSTIC RELEVANCE; NY-ESO-1; EXPRESSION; SYNOVIAL SARCOMA; GENE-EXPRESSION; NORMAL-TISSUES; MAGE-A; MELANOMA;
D O I
10.1016/j.canlet.2019.10.024
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Sarcomas are a group of heterogeneous malignancies of mesenchymal origin. Patient outcomes remain especially grim for those with recurrent or metastatic disease, and current therapeutic strategies have not significantly improved outcomes over the past few decades. This has led to a number of studies assessing novel therapies. Cancer testis antigens (CTAs) are tumor-associated antigens with physiologic expression in the testis and various malignancies, including sarcomas. Genes encoding CTAs include MAGE, NY-ESO-1, PRAME, TRAG-3/CSAGE, and SSX. The importance and function of CTAs in tumorigenesis have gained recognition in recent years. They are also proving as robust diagnostic and prognostic biomarkers. Therapeutically, antigens derived from CTAs are highly recognizable by T lymphocytes and therefore capable of generating a potent antitumor immune response. CTAs are, therefore, promising targets for novel immunotherapies. Here we review the emerging works on expression, function, and immunotherapeutic application of CTAs in sarcoma therapy.
引用
收藏
页码:54 / 60
页数:7
相关论文
共 97 条
[1]   Human Epidermal Growth Factor Receptor 2 (HER2) -Specific Chimeric Antigen Receptor-Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma [J].
Ahmed, Nabil ;
Brawley, Vita S. ;
Hegde, Meenakshi ;
Robertson, Catherine ;
Ghazi, Alexia ;
Gerken, Claudia ;
Liu, Enli ;
Dakhova, Olga ;
Ashoori, Aidin ;
Corder, Amanda ;
Gray, Tara ;
Wu, Meng-Fen ;
Liu, Hao ;
Hicks, John ;
Rainusso, Nino ;
Dotti, Gianpietro ;
Mei, Zhuyong ;
Grilley, Bambi ;
Gee, Adrian ;
Rooney, Cliona M. ;
Brenner, Malcolm K. ;
Heslop, Helen E. ;
Wels, Winfried S. ;
Wang, Lisa L. ;
Anderson, Peter ;
Gottschalk, Stephen .
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15) :1688-+
[2]   CTdatabase: a knowledge-base of high-throughput and curated data on cancer-testis antigens [J].
Almeida, Luiz Gonzaga ;
Sakabe, Noboru J. ;
deOliveira, Alice R. ;
Silva, Maria Cristina C. ;
Mundstein, Alex S. ;
Cohen, Tzeela ;
Chen, Yao-Tseng ;
Chua, Ramon ;
Gurung, Sita ;
Gnjatic, Sacha ;
Jungbluth, Achim A. ;
Caballero, Otavia L. ;
Bairoch, Amos ;
Kiesler, Eva ;
White, Sarah L. ;
Simpson, Andrew J. G. ;
Old, Lloyd J. ;
Camargo, Anamaria A. ;
Vasconcelos, Ana Tereza R. .
NUCLEIC ACIDS RESEARCH, 2009, 37 :D816-D819
[3]   Common Ewing sarcoma-associated antigens fail to induce natural T cell responses in both patients and healthy individuals [J].
Altvater, Bianca ;
Kailayangiri, Sareetha ;
Theimann, Nadine ;
Ahlmann, Martina ;
Farwick, Nicole ;
Chen, Christiane ;
Pscherer, Sibylle ;
Neumann, Ilka ;
Mrachatz, Gabriele ;
Hansmeier, Anna ;
Hardes, Jendrik ;
Gosheger, Georg ;
Juergens, Heribert ;
Rossig, Claudia .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2014, 63 (10) :1047-1060
[4]   MAGE antigen expression in monophasic and biphasic synovial sarcoma [J].
Antonescu, CR ;
Busam, KJ ;
Iversen, K ;
Kolb, D ;
Coplan, K ;
Spagnoli, GC ;
Ladanyi, M ;
Old, LJ ;
Jungbluth, AA .
HUMAN PATHOLOGY, 2002, 33 (02) :225-229
[5]  
Ayyoub Maha, 2004, Cancer Immun, V4, P7
[6]   Reduced human leukocyte antigen expression in advanced-stage Ewing sarcoma: implications for immune recognition [J].
Berghuis, Dagmar ;
de Hooge, Alfons S. K. ;
Santos, Susy J. ;
Horst, Danielle ;
Wertz, Emmanuel J. ;
van Eggermond, Marja C. ;
van den Elsen, Peter J. ;
Taminiau, Antonle H. M. ;
Ottaviano, Laura ;
Schaefer, Karl-Ludwig ;
Dirksen, Uta ;
Hooijberg, Erik ;
Mulder, Arend ;
Melief, Comelis J. M. ;
Egeler, R. Maarten ;
Schilham, Marco W. ;
Jordanova, Ekaterina S. ;
Hogendoorn, Pancras C. W. ;
Lankester, Arjan C. .
JOURNAL OF PATHOLOGY, 2009, 218 (02) :222-231
[7]   Surgery in reference centers improves survival of sarcoma patients: a nationwide study [J].
Blay, J. Y. ;
Honore, C. ;
Stoeckle, E. ;
Meeus, P. ;
Jafari, M. ;
Gouin, F. ;
Anract, P. ;
Ferron, G. ;
Rochwerger, A. ;
Ropars, M. ;
Carrere, S. ;
Marchal, F. ;
Sirveaux, F. ;
Di Marco, A. ;
Le Nail, L. R. ;
Guiramand, J. ;
Vaz, G. ;
Machiavello, J-C ;
Marco, O. ;
Causeret, S. ;
Gimbergues, P. ;
Fiorenza, F. ;
Chaigneau, L. ;
Guillemin, F. ;
Guilloit, J-M ;
Dujardin, F. ;
Spano, J-P ;
Ruzic, J-C ;
Michot, A. ;
Soibinet, P. ;
Bompas, E. ;
Chevreau, C. ;
Duffaud, F. ;
Rios, M. ;
Perrin, C. ;
Firmin, N. ;
Bertucci, F. ;
Le Pechoux, C. ;
Le Loarer, F. ;
Collard, O. ;
Karanian-Philippe, M. ;
Brahmi, M. ;
Dufresne, A. ;
Dupre, A. ;
Ducimetiere, F. ;
Giraud, A. ;
Perol, D. ;
Toulmonde, M. ;
Ray-Coquard, I ;
Italiano, A. .
ANNALS OF ONCOLOGY, 2019, 30 (07) :1143-1153
[8]   Tissue microarray evaluation of melanoma antigen E (MAGE) tumor-associated antigen expression - Potential indications for specific immunotherapy and prognostic relevance in squamous cell lung carcinoma [J].
Bolli, M ;
Kocher, T ;
Adamina, M ;
Guller, U ;
Dalquen, P ;
Haas, P ;
Mirlacher, M ;
Gambazzi, F ;
Harder, F ;
Heberer, M ;
Sauter, G ;
Spagnoli, GC .
ANNALS OF SURGERY, 2002, 236 (06) :785-793
[9]   Immunotherapy in Sarcoma: Future Horizons [J].
Burgess, Melissa ;
Gorantla, Vikram ;
Weiss, Kurt ;
Tawbi, Hussein .
CURRENT ONCOLOGY REPORTS, 2015, 17 (11)
[10]   Effects of CT-Xp Gene Knock down in Melanoma Cell Lines [J].
Caballero, Otavia L. ;
Cohen, Tzeela ;
Gurung, Sita ;
Chua, Ramon ;
Lee, Peishan ;
Chen, Yao-Tseng ;
Jat, Parmjit ;
Simpson, Andrew J. G. .
ONCOTARGET, 2013, 4 (04) :531-541